Antibiotice Financial Statements From 2010 to 2024

ATB Stock   2.69  0.01  0.37%   
Antibiotice financial statements provide useful quarterly and yearly information to potential Antibiotice Ia investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Antibiotice financial statements helps investors assess Antibiotice's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Antibiotice's valuation are summarized below:
Antibiotice Ia does not presently have any fundamental signals for analysis.
Check Antibiotice financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Antibiotice's main balance sheet or income statement drivers, such as , as well as many indicators such as . Antibiotice financial statements analysis is a perfect complement when working with Antibiotice Valuation or Volatility modules.
  
This module can also supplement various Antibiotice Technical models . Check out the analysis of Antibiotice Correlation against competitors.
No active fundamentals found

About Antibiotice Financial Statements

Antibiotice investors utilize fundamental indicators, such as revenue or net income, to predict how Antibiotice Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

Pair Trading with Antibiotice

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Antibiotice position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antibiotice will appreciate offsetting losses from the drop in the long position's value.

Moving together with Antibiotice Stock

  0.85AAG Aages SAPairCorr
  0.72ALU Alumil Rom IndustryPairCorr
The ability to find closely correlated positions to Antibiotice could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Antibiotice when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Antibiotice - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Antibiotice Ia to buy it.
The correlation of Antibiotice is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Antibiotice moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Antibiotice Ia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Antibiotice can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Antibiotice Stock

Antibiotice financial ratios help investors to determine whether Antibiotice Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antibiotice with respect to the benefits of owning Antibiotice security.